Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Australia

 

Quest Diagnostics changes strategy in emerging markets

Last week Healthcare Nova reported that US-based lab company Quest Diagnostics had sold its Indian medical diagnostics arm to Strand Life Sciences. We also reported that Quest has set up an international alliance of lab companies based in Brazil, Saudi Arabia, Korea, Hong Kong and Australia. Are the two moves connected? We speak to Quest's MD of global markets, Mark Machulcz to find out more about the group's change of strategy.

European domiciliary care provider breaks even in Asia

Buurtzorg, a Dutch domiciliary care business, is finally breaking even on the Asian market after a challenging first few years. We speak to Buurtzorg Asia's CEO Stephan Dyckerhoff about the difficulties of implementing his model in the far East.

Building international homecare businesses

Domiciliary homecare is regarded with much scepticism by private equity and many large nursing home groups. How do you build quality?  How do you compete with mom'n'pops? But some groups are definitely building scale internationally.

Medgate AI project to cut costs by 30-40%

Digital healthcare pioneer Medgate is evaluating opportunities in Germany and other European countries. A chatbot based on the 12 million telehealth sessions it has held over the past 19 years is in development and will be launched at the end of 2018 and should reduce costs by 30-40%, Medgate CEO and founder Andy Fischer tells Healthcare Nova. 

Medgate AI project to cut costs by 30-40%

Digital healthcare pioneer Medgate is evaluating opportunities in Germany and other European countries. A chatbot based on the 12 million telehealth sessions it has held over the past 19 years is in development and will be launched at the end of 2018 and should reduce costs by 30-40%, Medgate CEO and founder Andy Fischer tells Healthcare Europa. 

Find Us